PERCUTANEOUS ENDOSCOPIC GASTOSTOMY AND JEJUNOSTOMY – ONE CENTRE REVIEW (SUMMARY DATA 2002 – 2018)

Aims:

The aim of study was to review number of percutaneous gastrostomies (PEG) and jejunostomies (PEJ) in PEG Center of Internal Clinic 3 rd Medical Faculty of Charles University and Thomayer's Hospitalin Prague.

Methods:

PEG is method of choice for application of enteral nutrition for more than 4 – 6 weeks, PEJ is introduced, when jejunal nutrition is indicated or introduction of PEG is contraindicated (stomach cancer) or technically impossible.

Results:

Since 2002 to 2018 1587 PEGs in 1526 patients (707 men, 819 women, aver. age 69,5 years, 6 weeks – 98 years) were introduced, 830 PEGs in patients over 70 years (351 men, 479 women), 169 PEGs in children under 15 years (80 boys, 59 girls, aver. age 2,1 years) 35 PEJs were introduced in 35 patients in the average age of 52,4 years (23 men, 12 women), 15 of them with stomach cancer.

312 patients (20,6%) have had Oncological diagnose (225 men, 89 women. aver age 57,3 years), in 227 of them (14,8%) Head end neck cancer was found (165 men, 62 women, aver age 61,4 years), in 92 patients PEG were introduced before radiotherapy of surgery, in 153 patients pull technique (Gauderer-Ponsky or Sacks-Vine) and in 74 push-through techniquie (Russell) were used.

37 pts have had after stomach resection, in 36 of them PEG and in next 18 PEJ were successfully introduced, in 2 of them transthoracally.

The rate of early complications (in 30 days) was low – 10,5%, the mortality was 0,06% (1 patient), 2,4% had serious complications (2,1% aspiration pneumonia) and 9,2% of complications were non-serious (light) (8,4% stoma site infection.

Conclusions:

Percutaneous endoscopic gastrostomy and jejunostomy are safe and easy to perform methods for long term application of enteral nutrition.